A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.

Thottakara, Tilo; Lund, Natalie; Krämer, Elisabeth; Kirchhof, Paulus; Carrier, Lucie; Patten, Monica

Thottakara, Tilo; Lund, Natalie; Krämer, Elisabeth; Kirchhof, Paulus; Carrier, Lucie; Patten, Monica.

Afiliação

Thottakara T; Department of Cardiology, University Heart and Vascular Center Hamburg, 20253 Hamburg, Germany.
Lund N; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Krämer E; Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California, San Francisco, CA 94158, USA.
Kirchhof P; Department of Cardiology, University Heart and Vascular Center Hamburg, 20253 Hamburg, Germany.
Carrier L; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Patten M; Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Biomolecules ; 11(11)2021 11 18.

Article em En | MEDLINE | ID: mdl-34827715

Assuntos

Cardiomiopatia Hipertrófica; Adulto; Fibrose; Humanos; MicroRNAs; Pessoa de Meia-Idade

Palavras-chave

biomarker; cardiac fibrosis; circulating miRNA; hypertrophic cardiomyopathy; ventricular hypertrophy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica Tipo de estudo: Screening_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Biomolecules Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google